Interpretation of Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients with Statin Intolerance:A guiding file for lipid management in Chinese population
It is well-known that elevated low-density lipoprotein cholesterol(LDL-C)is a causal risk factor for ath-erosclerotic cardiovascular disease(ASCVD),Statins are cornerstone drugs for the cause-based treatment of ASCVD,which has created a new era for ASCVD therapy.However,statin intolerance is not clinically uncommon,which there are several issue with confusion and misunderstandings.Hence,a file named Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients With Statin Intolerance,like a navigator,has recently been published written by a team of experts from the Cardiovascular Metabolic Medicine Professional Committee,Expert Committee of the National Center for Cardiovascular Diseases aiming to enhance the standardized clinical application of statins and improve the pre-vention and clinical outcome.In this article,author briefly summarized the key points of above consensus in order to help-ing to comprehending the content of the consensus suggestions.
NETL
NSTL
万方数据
